Xarelto has generated nearly $2 billion in revenue since it was approved in 2011. Read more
Lawyers in the Mass Torts Section at Beasley Allen continue to pursue Risperdal claims on behalf of individuals who have been injured as a result of taking Risperdal, the brand name drug man... Read more
A Philadelphia jury returned a $2.5 million in damages against a Johnson & Johnson unit in the first verdict over the antipsychotic drug Risperdal’s connections to abnormal breast... Read more
Janssen Pharmaceuticals, Inc., a Johnson & Johnson (J&J) unit, has agreed to settle with plaintiffs in 76 suits pending in Pennsylvania court over alleged birth defects in the babies... Read more
Lawyers in the Mass Torts Section at Beasley Allen continue to handle Risperdal claims on behalf of individuals who have been injured as a result of taking the drug. Risperdal is the brand n... Read more
A Philadelphia state jury returned a verdict against Janssen Pharmaceuticals Inc. in a Topamax lawsuit last month. The company will have to pay more than $10 million to the parents of a chil... Read more
The U.S. Food and Drug Administration (FDA) has approved labeling changes for powerful pain-relieving patches made by Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson. This... Read more
Janssen Pharmaceuticals Inc. and its parent company Johnson & Johnson have agreed to resolve charges of improper marketing and advertising of the powerful anti-psychotic drugs Risperdal... Read more
An Arkansas judge fined Johnson & Johnson and a subsidiary more than $1.1 billion last month after a jury found that the companies downplayed and hid risks associated with taking the an... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.